These observations confirmed that CD4+ T cells preferentially interact with MHC-II+ antigen-presenting cells at the invasive tumour margin, whereas CD8+ T cells require MHC-I expression on tumour cells to exert their effector functions in vivo. Here, CD4 is linked to neoplasm.